ATE109828T1 - Sekretion eines dem insulin ähnlichen wachstumsfaktors in e. coli. - Google Patents

Sekretion eines dem insulin ähnlichen wachstumsfaktors in e. coli.

Info

Publication number
ATE109828T1
ATE109828T1 AT88870067T AT88870067T ATE109828T1 AT E109828 T1 ATE109828 T1 AT E109828T1 AT 88870067 T AT88870067 T AT 88870067T AT 88870067 T AT88870067 T AT 88870067T AT E109828 T1 ATE109828 T1 AT E109828T1
Authority
AT
Austria
Prior art keywords
insulin
secretion
coli
growth factor
igf
Prior art date
Application number
AT88870067T
Other languages
English (en)
Inventor
Edith Wong
Michael Louis Bittner
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of ATE109828T1 publication Critical patent/ATE109828T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT88870067T 1987-04-23 1988-04-22 Sekretion eines dem insulin ähnlichen wachstumsfaktors in e. coli. ATE109828T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4189687A 1987-04-23 1987-04-23

Publications (1)

Publication Number Publication Date
ATE109828T1 true ATE109828T1 (de) 1994-08-15

Family

ID=21918925

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88870067T ATE109828T1 (de) 1987-04-23 1988-04-22 Sekretion eines dem insulin ähnlichen wachstumsfaktors in e. coli.

Country Status (6)

Country Link
EP (1) EP0288451B1 (de)
AT (1) ATE109828T1 (de)
AU (1) AU607209B2 (de)
CA (1) CA1314507C (de)
DE (1) DE3850995T2 (de)
ES (1) ES2007309T3 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963665A (en) * 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
US4876242A (en) * 1987-09-21 1989-10-24 Merck & Co., Inc. Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast
DE3901681A1 (de) * 1989-01-21 1990-07-26 Behringwerke Ag Signalpeptid fuer die sekretion von peptiden in escherichia coli, verfahren zu seiner gewinnung und seine verwendung
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
WO1992003560A1 (en) * 1990-08-28 1992-03-05 E.I. Du Pont De Nemours And Company A method for rapid selection of efficient secretion vectors
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
WO1998011913A1 (en) * 1996-09-16 1998-03-26 Dalhousie University Use of igf-i for the treatment of polycystic kidney disease and related indications
US6593290B1 (en) 1996-11-01 2003-07-15 Genentech, Inc. Treatment of inner ear hair cells
US6156728A (en) 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
AU762351B2 (en) 1999-01-06 2003-06-26 Genentech Inc. Insulin-like growth factor (IGF) I mutant variants
JP2002535967A (ja) 1999-01-06 2002-10-29 ジェネンテック・インコーポレーテッド インシュリン様成長因子（ｉｇｆ）ｉ変異体
AU763039B2 (en) 1999-04-08 2003-07-10 Genentech Inc. Composition based on oppositely-charged polypeptides
ATE389416T1 (de) 2000-05-16 2008-04-15 Genentech Inc Behandlung von knorpelerkrankungen
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
EP2274978B1 (de) 2003-09-12 2015-05-20 Tercica, Inc. Verfahren zur Behandlung von IGF-1 (insulin-like growth factor 1)-Mangel
CA2546157C (en) 2003-11-21 2014-07-22 Dow Global Technolgies Inc. Improved expression systems with sec-system secretion
BRPI0513826A2 (pt) 2004-07-26 2010-06-22 Dow Global Technologies Inc processo para expressão de proteìna melhorada através de engenharia de cepa
ES2577292T3 (es) 2005-11-07 2016-07-14 Genentech, Inc. Polipéptidos de unión con secuencias hipervariables de VH/VL diversificadas y consenso
CA2631327C (en) 2005-12-02 2015-10-13 Genentech, Inc. Her2 binding polypeptides and uses thereof
RU2337964C2 (ru) * 2006-11-21 2008-11-10 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pAS-2, КОДИРУЮЩАЯ ПОЛИПЕПТИД ПРОИНСУЛИНА Aspart ЧЕЛОВЕКА, И ШТАММ БАКТЕРИЙ Escherichia coli BAS2 - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ПРОИНСУЛИНА Aspart
EP2468869B1 (de) 2007-01-31 2015-03-18 Pfenex Inc. Bakterielle Leader-Sequenzen für erhöhte Expression
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US8318481B2 (en) 2007-12-07 2012-11-27 Pfenex Inc. High copy number self-replicating plasmids in pseudomonas
EP3368696A1 (de) * 2015-10-30 2018-09-05 Synlogic Operating Company, Inc. Manipulierte bakterien zur behandlung von krankheiten, die von reduzierter darmentzündung und/oder verstärkter darmschleimhautbarriere profitieren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336336A (en) * 1979-01-12 1982-06-22 President And Fellows Of Harvard College Fused gene and method of making and using same
EP0138644B1 (de) * 1983-08-23 1991-08-21 Mitsubishi Kasei Corporation Plasmidvektoren

Also Published As

Publication number Publication date
AU607209B2 (en) 1991-02-28
AU1509188A (en) 1988-10-27
EP0288451B1 (de) 1994-08-10
EP0288451A2 (de) 1988-10-26
DE3850995T2 (de) 1995-03-16
ES2007309T3 (es) 1994-11-01
CA1314507C (en) 1993-03-16
DE3850995D1 (de) 1994-09-15
EP0288451A3 (en) 1989-04-19
ES2007309A4 (es) 1989-06-16

Similar Documents

Publication Publication Date Title
ATE109828T1 (de) Sekretion eines dem insulin ähnlichen wachstumsfaktors in e. coli.
NZ190524A (en) Recombinant dna method for producing specific protein or polypeptide cleaving of bacterial gene for extracellular or periplasmic carrier protein
DE69534822D1 (de) Verfahren zur bakteriellen herstellung von heterologen polypeptiden mit disulfidbrücke
KR830005355A (ko) 박테리아숙주내에서 각종 폴리펩타이드를 합성하는 방법 및 폴리펩타이드 dna
EP0375724A4 (en) Biologically active bactericidal/permeability-increasing protein fragments
DE3586960D1 (de)
SE8303626D0 (sv) A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
FI965220A0 (fi) Ei-toksinen, ei-toksigeeninen, ei-patogeeninen Fusarium-ilmentämissysteemi ja siinä käytettävät promootterit ja terminaattorit
ES8603957A1 (es) Procedimiento para obtener una proteina heterologa para levadura
ATE102651T1 (de) Verfahren zur gentechnischen herstellung von antikoerpern.
AU5910086A (en) Bacterial enzymes
FI865003A0 (fi) Menetelmä trombiini-inhibiittorien tuottamiseksi
NO854018L (no) Antibiotisk virksomt a 40926 kompleks og dets rene faktore r pa, pb, a, b og bo.
NO885555D0 (no) Produksjon av renset, biologisk aktivt, bakterielt produsert rekombinant humant csf-1.
ATE89318T1 (de) Verfahren zur gentechnologischengewinnung von proteinen unter verwendung gramnegativer wirtzellen.
PT677110E (pt) Bacteria lactica recombinante contendo um promotor inserido
ATE142263T1 (de) Verfahren zur herstellung von fremdproteinen in streptomyceten
DE3687112D1 (de) Verfahren zur ausscheidung von genprodukten in das wachstumsmedium von gram-negativen bakterien.
PT93614A (pt) Estirpe de levedura melhorada para a producao de proteinas heterologas maduras,em particular hirudina, e processo para a preparacao da hirudina correspondente
FI895184A0 (fi) Menetelmä fuusioproteiinien valmistamiseksi Streptomyces-lajeissa
ES8704513A1 (es) Un metodo para producir una proteina heterologa
Gautvik et al. Production of human parathyroid hormone from microorganisms
KR860002569A (ko) 인체인슐린-유사생장인자의 제조방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time